nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—rheumatoid arthritis	0.383	1	CbGaD
Nepafenac—PTGS2—Sulfasalazine—rheumatoid arthritis	0.107	0.238	CbGbCtD
Nepafenac—PTGS2—Triamcinolone—rheumatoid arthritis	0.107	0.238	CbGbCtD
Nepafenac—PTGS2—Betamethasone—rheumatoid arthritis	0.0922	0.204	CbGbCtD
Nepafenac—PTGS1—Sulfasalazine—rheumatoid arthritis	0.0907	0.201	CbGbCtD
Nepafenac—PTGS2—Dexamethasone—rheumatoid arthritis	0.0536	0.119	CbGbCtD
Nepafenac—Corneal thinning—Dexamethasone—rheumatoid arthritis	0.00355	0.0312	CcSEcCtD
Nepafenac—Corneal thinning—Betamethasone—rheumatoid arthritis	0.00355	0.0312	CcSEcCtD
Nepafenac—Vitreous detachment—Betamethasone—rheumatoid arthritis	0.00293	0.0257	CcSEcCtD
Nepafenac—Vitreous detachment—Dexamethasone—rheumatoid arthritis	0.00293	0.0257	CcSEcCtD
Nepafenac—Corneal oedema—Betamethasone—rheumatoid arthritis	0.00229	0.0201	CcSEcCtD
Nepafenac—Corneal oedema—Dexamethasone—rheumatoid arthritis	0.00229	0.0201	CcSEcCtD
Nepafenac—Ulcerative keratitis—Prednisolone—rheumatoid arthritis	0.00228	0.02	CcSEcCtD
Nepafenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—rheumatoid arthritis	0.00216	0.0511	CbGpPWpGaD
Nepafenac—Rheumatoid arthritis—Cyclosporine—rheumatoid arthritis	0.0021	0.0184	CcSEcCtD
Nepafenac—Eye swelling—Cyclosporine—rheumatoid arthritis	0.00194	0.017	CcSEcCtD
Nepafenac—Sensation of foreign body—Cyclosporine—rheumatoid arthritis	0.00194	0.017	CcSEcCtD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—ANXA3—rheumatoid arthritis	0.00182	0.0431	CbGpPWpGaD
Nepafenac—Sensation of foreign body—Prednisolone—rheumatoid arthritis	0.00177	0.0155	CcSEcCtD
Nepafenac—Conjunctival oedema—Dexamethasone—rheumatoid arthritis	0.00173	0.0152	CcSEcCtD
Nepafenac—Conjunctival oedema—Betamethasone—rheumatoid arthritis	0.00173	0.0152	CcSEcCtD
Nepafenac—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—rheumatoid arthritis	0.00172	0.0405	CbGpPWpGaD
Nepafenac—Ulcerative keratitis—Prednisone—rheumatoid arthritis	0.00166	0.0145	CcSEcCtD
Nepafenac—Ocular discomfort—Methotrexate—rheumatoid arthritis	0.00154	0.0135	CcSEcCtD
Nepafenac—Sensation of foreign body—Betamethasone—rheumatoid arthritis	0.00148	0.0129	CcSEcCtD
Nepafenac—Sensation of foreign body—Dexamethasone—rheumatoid arthritis	0.00148	0.0129	CcSEcCtD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—ANXA3—rheumatoid arthritis	0.00145	0.0342	CbGpPWpGaD
Nepafenac—Conjunctival hyperaemia—Cyclosporine—rheumatoid arthritis	0.00144	0.0126	CcSEcCtD
Nepafenac—PTGS1—Eicosanoid Synthesis—PTGES—rheumatoid arthritis	0.00141	0.0332	CbGpPWpGaD
Nepafenac—Impaired healing—Prednisolone—rheumatoid arthritis	0.00133	0.0117	CcSEcCtD
Nepafenac—Intraocular pressure increased—Prednisolone—rheumatoid arthritis	0.00131	0.0115	CcSEcCtD
Nepafenac—Conjunctival hyperaemia—Prednisolone—rheumatoid arthritis	0.00131	0.0115	CcSEcCtD
Nepafenac—Impaired healing—Hydrocortisone—rheumatoid arthritis	0.0013	0.0114	CcSEcCtD
Nepafenac—Intraocular pressure increased—Hydrocortisone—rheumatoid arthritis	0.00128	0.0112	CcSEcCtD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—RCAN1—rheumatoid arthritis	0.00123	0.0291	CbGpPWpGaD
Nepafenac—Impaired healing—Triamcinolone—rheumatoid arthritis	0.00123	0.0107	CcSEcCtD
Nepafenac—Impaired healing—Methylprednisolone—rheumatoid arthritis	0.00122	0.0107	CcSEcCtD
Nepafenac—Intraocular pressure increased—Triamcinolone—rheumatoid arthritis	0.00121	0.0106	CcSEcCtD
Nepafenac—Intraocular pressure increased—Methylprednisolone—rheumatoid arthritis	0.0012	0.0105	CcSEcCtD
Nepafenac—PTGS2—Eicosanoid Synthesis—PTGES—rheumatoid arthritis	0.00112	0.0263	CbGpPWpGaD
Nepafenac—Impaired healing—Dexamethasone—rheumatoid arthritis	0.00111	0.00975	CcSEcCtD
Nepafenac—Impaired healing—Betamethasone—rheumatoid arthritis	0.00111	0.00975	CcSEcCtD
Nepafenac—Intraocular pressure increased—Dexamethasone—rheumatoid arthritis	0.00109	0.00959	CcSEcCtD
Nepafenac—Conjunctival hyperaemia—Betamethasone—rheumatoid arthritis	0.00109	0.00959	CcSEcCtD
Nepafenac—Intraocular pressure increased—Betamethasone—rheumatoid arthritis	0.00109	0.00959	CcSEcCtD
Nepafenac—Conjunctival hyperaemia—Dexamethasone—rheumatoid arthritis	0.00109	0.00959	CcSEcCtD
Nepafenac—Endophthalmitis—Dexamethasone—rheumatoid arthritis	0.00101	0.00886	CcSEcCtD
Nepafenac—Endophthalmitis—Betamethasone—rheumatoid arthritis	0.00101	0.00886	CcSEcCtD
Nepafenac—Impaired healing—Prednisone—rheumatoid arthritis	0.000968	0.00849	CcSEcCtD
Nepafenac—Intraocular pressure increased—Prednisone—rheumatoid arthritis	0.000952	0.00835	CcSEcCtD
Nepafenac—Keratitis—Prednisolone—rheumatoid arthritis	0.000889	0.00779	CcSEcCtD
Nepafenac—PTGS1—Eicosanoid Synthesis—ALOX5—rheumatoid arthritis	0.000883	0.0208	CbGpPWpGaD
Nepafenac—Endophthalmitis—Prednisone—rheumatoid arthritis	0.00088	0.00771	CcSEcCtD
Nepafenac—Cataract—Leflunomide—rheumatoid arthritis	0.000862	0.00756	CcSEcCtD
Nepafenac—Eye disorder—Auranofin—rheumatoid arthritis	0.000848	0.00744	CcSEcCtD
Nepafenac—Hypertension—Ergocalciferol—rheumatoid arthritis	0.000837	0.00734	CcSEcCtD
Nepafenac—Blood pressure increased—Leflunomide—rheumatoid arthritis	0.000821	0.0072	CcSEcCtD
Nepafenac—Impaired healing—Methotrexate—rheumatoid arthritis	0.000809	0.0071	CcSEcCtD
Nepafenac—Visual acuity reduced—Betamethasone—rheumatoid arthritis	0.000809	0.00709	CcSEcCtD
Nepafenac—Visual acuity reduced—Dexamethasone—rheumatoid arthritis	0.000809	0.00709	CcSEcCtD
Nepafenac—Blepharitis—Dexamethasone—rheumatoid arthritis	0.000782	0.00685	CcSEcCtD
Nepafenac—Blepharitis—Betamethasone—rheumatoid arthritis	0.000782	0.00685	CcSEcCtD
Nepafenac—PTGS1—Arachidonic acid metabolism—PTGES—rheumatoid arthritis	0.000781	0.0184	CbGpPWpGaD
Nepafenac—Dermatitis atopic—Prednisolone—rheumatoid arthritis	0.000779	0.00683	CcSEcCtD
Nepafenac—Angiopathy—Penicillamine—rheumatoid arthritis	0.000761	0.00667	CcSEcCtD
Nepafenac—Keratitis—Betamethasone—rheumatoid arthritis	0.000741	0.0065	CcSEcCtD
Nepafenac—Keratitis—Dexamethasone—rheumatoid arthritis	0.000741	0.0065	CcSEcCtD
Nepafenac—Dermatitis atopic—Triamcinolone—rheumatoid arthritis	0.000716	0.00628	CcSEcCtD
Nepafenac—PTGS2—Eicosanoid Synthesis—ALOX5—rheumatoid arthritis	0.000701	0.0165	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—PRTN3—rheumatoid arthritis	0.000695	0.0164	CbGpPWpGaD
Nepafenac—PTGS2—Fluocinonide—Methylprednisolone—rheumatoid arthritis	0.000694	0.159	CbGdCrCtD
Nepafenac—Lacrimation increased—Cyclosporine—rheumatoid arthritis	0.000687	0.00603	CcSEcCtD
Nepafenac—Diabetes mellitus—Leflunomide—rheumatoid arthritis	0.000685	0.006	CcSEcCtD
Nepafenac—PTGS2—Fluocinonide—Dexamethasone—rheumatoid arthritis	0.000683	0.156	CbGdCrCtD
Nepafenac—PTGS2—Fluocinonide—Betamethasone—rheumatoid arthritis	0.000683	0.156	CbGdCrCtD
Nepafenac—Eye irritation—Prednisolone—rheumatoid arthritis	0.000675	0.00592	CcSEcCtD
Nepafenac—PTGS2—Fluocinonide—Triamcinolone—rheumatoid arthritis	0.000667	0.153	CbGdCrCtD
Nepafenac—Cataract—Cyclosporine—rheumatoid arthritis	0.000665	0.00583	CcSEcCtD
Nepafenac—PTGS2—Arachidonic acid metabolism—PTGES—rheumatoid arthritis	0.00062	0.0146	CbGpPWpGaD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Penicillamine—rheumatoid arthritis	0.000617	0.00541	CcSEcCtD
Nepafenac—Arthritis—Leflunomide—rheumatoid arthritis	0.000613	0.00537	CcSEcCtD
Nepafenac—PTGS1—Overview of nanoparticle effects—PTK2—rheumatoid arthritis	0.000604	0.0143	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TNFSF13B—rheumatoid arthritis	0.000594	0.014	CbGpPWpGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—NFATC1—rheumatoid arthritis	0.000593	0.014	CbGpPWpGaD
Nepafenac—Cataract—Hydrocortisone—rheumatoid arthritis	0.000591	0.00518	CcSEcCtD
Nepafenac—Skin disorder—Penicillamine—rheumatoid arthritis	0.000579	0.00507	CcSEcCtD
Nepafenac—Dermatitis atopic—Prednisone—rheumatoid arthritis	0.000566	0.00496	CcSEcCtD
Nepafenac—Cataract—Triamcinolone—rheumatoid arthritis	0.000557	0.00488	CcSEcCtD
Nepafenac—Diclofenac—ALOX5—rheumatoid arthritis	0.000533	0.117	CrCbGaD
Nepafenac—Diabetes mellitus—Cyclosporine—rheumatoid arthritis	0.000529	0.00463	CcSEcCtD
Nepafenac—Dry eye—Hydrocortisone—rheumatoid arthritis	0.00052	0.00456	CcSEcCtD
Nepafenac—Eye pain—Cyclosporine—rheumatoid arthritis	0.000509	0.00446	CcSEcCtD
Nepafenac—Cataract—Dexamethasone—rheumatoid arthritis	0.000505	0.00443	CcSEcCtD
Nepafenac—Cataract—Betamethasone—rheumatoid arthritis	0.000505	0.00443	CcSEcCtD
Nepafenac—PTGS1—Overview of nanoparticle effects—CRP—rheumatoid arthritis	0.000496	0.0117	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—ALOX5—rheumatoid arthritis	0.000491	0.0116	CbGpPWpGaD
Nepafenac—Diabetes mellitus—Prednisolone—rheumatoid arthritis	0.000481	0.00422	CcSEcCtD
Nepafenac—PTGS2—Overview of nanoparticle effects—PTK2—rheumatoid arthritis	0.000479	0.0113	CbGpPWpGaD
Nepafenac—Arthritis—Cyclosporine—rheumatoid arthritis	0.000473	0.00415	CcSEcCtD
Nepafenac—Nausea—Ergocalciferol—rheumatoid arthritis	0.00047	0.00412	CcSEcCtD
Nepafenac—Diabetes mellitus—Hydrocortisone—rheumatoid arthritis	0.00047	0.00412	CcSEcCtD
Nepafenac—PTGS1—Overview of nanoparticle effects—FN1—rheumatoid arthritis	0.000458	0.0108	CbGpPWpGaD
Nepafenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—rheumatoid arthritis	0.000457	0.0108	CbGpPWpGaD
Nepafenac—Pruritus—Auranofin—rheumatoid arthritis	0.000456	0.004	CcSEcCtD
Nepafenac—Dry eye—Betamethasone—rheumatoid arthritis	0.000444	0.00389	CcSEcCtD
Nepafenac—Dry eye—Dexamethasone—rheumatoid arthritis	0.000444	0.00389	CcSEcCtD
Nepafenac—Diabetes mellitus—Triamcinolone—rheumatoid arthritis	0.000442	0.00388	CcSEcCtD
Nepafenac—Diabetes mellitus—Methylprednisolone—rheumatoid arthritis	0.000441	0.00387	CcSEcCtD
Nepafenac—Diclofenac—CXCL8—rheumatoid arthritis	0.000441	0.0972	CrCbGaD
Nepafenac—Cataract—Prednisone—rheumatoid arthritis	0.00044	0.00386	CcSEcCtD
Nepafenac—Hypersensitivity—Penicillamine—rheumatoid arthritis	0.000439	0.00385	CcSEcCtD
Nepafenac—Sinusitis—Leflunomide—rheumatoid arthritis	0.000431	0.00378	CcSEcCtD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—AHR—rheumatoid arthritis	0.000427	0.0101	CbGpPWpGaD
Nepafenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—rheumatoid arthritis	0.000424	0.01	CbGpPWpGaD
Nepafenac—PTGS2—Fluticasone Propionate—Methylprednisolone—rheumatoid arthritis	0.000419	0.0957	CbGdCrCtD
Nepafenac—PTGS2—Fluticasone Propionate—Dexamethasone—rheumatoid arthritis	0.000412	0.0942	CbGdCrCtD
Nepafenac—PTGS2—Fluticasone Propionate—Betamethasone—rheumatoid arthritis	0.000412	0.0942	CbGdCrCtD
Nepafenac—Vomiting—Auranofin—rheumatoid arthritis	0.00041	0.00359	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—rheumatoid arthritis	0.000403	0.00952	CbGpPWpGaD
Nepafenac—PTGS2—Fluticasone Propionate—Triamcinolone—rheumatoid arthritis	0.000403	0.0921	CbGdCrCtD
Nepafenac—Diabetes mellitus—Dexamethasone—rheumatoid arthritis	0.000401	0.00352	CcSEcCtD
Nepafenac—Diabetes mellitus—Betamethasone—rheumatoid arthritis	0.000401	0.00352	CcSEcCtD
Nepafenac—Immune system disorder—Azathioprine—rheumatoid arthritis	0.000394	0.00346	CcSEcCtD
Nepafenac—PTGS2—Overview of nanoparticle effects—CRP—rheumatoid arthritis	0.000394	0.00929	CbGpPWpGaD
Nepafenac—Ketoprofen—CXCL8—rheumatoid arthritis	0.000391	0.0861	CrCbGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—ALOX5—rheumatoid arthritis	0.00039	0.0092	CbGpPWpGaD
Nepafenac—Eye pain—Betamethasone—rheumatoid arthritis	0.000387	0.00339	CcSEcCtD
Nepafenac—Eye pain—Dexamethasone—rheumatoid arthritis	0.000387	0.00339	CcSEcCtD
Nepafenac—Eye disorder—Leflunomide—rheumatoid arthritis	0.000385	0.00338	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—NFATC1—rheumatoid arthritis	0.000383	0.00905	CbGpPWpGaD
Nepafenac—Nausea—Auranofin—rheumatoid arthritis	0.000383	0.00336	CcSEcCtD
Nepafenac—Vomiting—Penicillamine—rheumatoid arthritis	0.000379	0.00332	CcSEcCtD
Nepafenac—Immune system disorder—Leflunomide—rheumatoid arthritis	0.000372	0.00326	CcSEcCtD
Nepafenac—PTGS2—Overview of nanoparticle effects—FN1—rheumatoid arthritis	0.000363	0.00857	CbGpPWpGaD
Nepafenac—Ketorolac—PTGS2—rheumatoid arthritis	0.000363	0.0799	CrCbGaD
Nepafenac—Nausea—Penicillamine—rheumatoid arthritis	0.000354	0.0031	CcSEcCtD
Nepafenac—Diabetes mellitus—Prednisone—rheumatoid arthritis	0.00035	0.00306	CcSEcCtD
Nepafenac—Bromfenac—PTGS2—rheumatoid arthritis	0.000348	0.0766	CrCbGaD
Nepafenac—PTGS2—Spinal Cord Injury—ACAN—rheumatoid arthritis	0.000341	0.00806	CbGpPWpGaD
Nepafenac—Vision blurred—Leflunomide—rheumatoid arthritis	0.000338	0.00296	CcSEcCtD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—rheumatoid arthritis	0.000334	0.00788	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—PTGS2—rheumatoid arthritis	0.000332	0.00785	CbGpPWpGaD
Nepafenac—Sinusitis—Cyclosporine—rheumatoid arthritis	0.000332	0.00291	CcSEcCtD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—CSF2—rheumatoid arthritis	0.00033	0.00779	CbGpPWpGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—rheumatoid arthritis	0.000325	0.00766	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—CXCL8—rheumatoid arthritis	0.000322	0.00761	CbGpPWpGaD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—rheumatoid arthritis	0.000321	0.00282	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—ALOX5—rheumatoid arthritis	0.000312	0.00737	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—GATA3—rheumatoid arthritis	0.000311	0.00735	CbGpPWpGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—rheumatoid arthritis	0.00031	0.00732	CbGpPWpGaD
Nepafenac—Hypertension—Leflunomide—rheumatoid arthritis	0.00031	0.00272	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—ZFP36—rheumatoid arthritis	0.000304	0.00718	CbGpPWpGaD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—rheumatoid arthritis	0.000303	0.00266	CcSEcCtD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—rheumatoid arthritis	0.000302	0.00713	CbGpPWpGaD
Nepafenac—Skin disorder—Azathioprine—rheumatoid arthritis	0.000301	0.00264	CcSEcCtD
Nepafenac—Dry mouth—Leflunomide—rheumatoid arthritis	0.000299	0.00262	CcSEcCtD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—rheumatoid arthritis	0.000297	0.00702	CbGpPWpGaD
Nepafenac—Tiaprofenic acid—PTGS2—rheumatoid arthritis	0.000296	0.0651	CrCbGaD
Nepafenac—Diabetes mellitus—Methotrexate—rheumatoid arthritis	0.000292	0.00256	CcSEcCtD
Nepafenac—Angiopathy—Cyclosporine—rheumatoid arthritis	0.000289	0.00253	CcSEcCtD
Nepafenac—Nervous system disorder—Leflunomide—rheumatoid arthritis	0.000287	0.00252	CcSEcCtD
Nepafenac—Skin disorder—Leflunomide—rheumatoid arthritis	0.000284	0.00249	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—rheumatoid arthritis	0.000278	0.00655	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—MPO—rheumatoid arthritis	0.000277	0.00653	CbGpPWpGaD
Nepafenac—PTGS1—Eicosanoid Synthesis—PTGS2—rheumatoid arthritis	0.000276	0.00651	CbGpPWpGaD
Nepafenac—Magnesium salicylate—PTGS2—rheumatoid arthritis	0.000275	0.0605	CrCbGaD
Nepafenac—Fenbufen—PTGS2—rheumatoid arthritis	0.000269	0.0592	CrCbGaD
Nepafenac—PTGS2—Spinal Cord Injury—MIF—rheumatoid arthritis	0.000268	0.00632	CbGpPWpGaD
Nepafenac—Gastrointestinal disorder—Azathioprine—rheumatoid arthritis	0.000268	0.00235	CcSEcCtD
Nepafenac—Eye disorder—Hydrocortisone—rheumatoid arthritis	0.000264	0.00232	CcSEcCtD
Nepafenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—rheumatoid arthritis	0.000263	0.0062	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—SAA1—rheumatoid arthritis	0.000263	0.0062	CbGpPWpGaD
Nepafenac—Vision blurred—Cyclosporine—rheumatoid arthritis	0.000261	0.00229	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PRKCQ—rheumatoid arthritis	0.00026	0.00614	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TNFSF13—rheumatoid arthritis	0.000259	0.0061	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—CXCL8—rheumatoid arthritis	0.000256	0.00604	CbGpPWpGaD
Nepafenac—Immune system disorder—Hydrocortisone—rheumatoid arthritis	0.000255	0.00224	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.000253	0.00222	CcSEcCtD
Nepafenac—Eye disorder—Methylprednisolone—rheumatoid arthritis	0.000248	0.00218	CcSEcCtD
Nepafenac—PTGS2—Selenium Micronutrient Network—ALOX5—rheumatoid arthritis	0.000248	0.00585	CbGpPWpGaD
Nepafenac—Magnesium salicylate—ALB—rheumatoid arthritis	0.000245	0.0539	CrCbGaD
Nepafenac—Angiopathy—Methylprednisolone—rheumatoid arthritis	0.000241	0.00211	CcSEcCtD
Nepafenac—Immune system disorder—Methylprednisolone—rheumatoid arthritis	0.00024	0.0021	CcSEcCtD
Nepafenac—Hypertension—Cyclosporine—rheumatoid arthritis	0.000239	0.0021	CcSEcCtD
Nepafenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—rheumatoid arthritis	0.000239	0.00563	CbGpPWpGaD
Nepafenac—Vision blurred—Prednisolone—rheumatoid arthritis	0.000237	0.00208	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	0.000234	0.00205	CcSEcCtD
Nepafenac—Salsalate—PTGS2—rheumatoid arthritis	0.000234	0.0515	CrCbGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—rheumatoid arthritis	0.000231	0.00545	CbGpPWpGaD
Nepafenac—Dry mouth—Cyclosporine—rheumatoid arthritis	0.000231	0.00202	CcSEcCtD
Nepafenac—PTGS2—C-MYB transcription factor network—ETS1—rheumatoid arthritis	0.000229	0.00541	CbGpPWpGaD
Nepafenac—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.000228	0.002	CcSEcCtD
Nepafenac—PTGS2—C-MYB transcription factor network—MPO—rheumatoid arthritis	0.000228	0.00538	CbGpPWpGaD
Nepafenac—Eye disorder—Dexamethasone—rheumatoid arthritis	0.000226	0.00198	CcSEcCtD
Nepafenac—Eye disorder—Betamethasone—rheumatoid arthritis	0.000226	0.00198	CcSEcCtD
Nepafenac—PTGS1—Overview of nanoparticle effects—TNF—rheumatoid arthritis	0.000224	0.0053	CbGpPWpGaD
Nepafenac—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000222	0.00194	CcSEcCtD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—rheumatoid arthritis	0.00022	0.0052	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—MPO—rheumatoid arthritis	0.00022	0.00518	CbGpPWpGaD
Nepafenac—Skin disorder—Cyclosporine—rheumatoid arthritis	0.000219	0.00192	CcSEcCtD
Nepafenac—Angiopathy—Dexamethasone—rheumatoid arthritis	0.000219	0.00192	CcSEcCtD
Nepafenac—Angiopathy—Betamethasone—rheumatoid arthritis	0.000219	0.00192	CcSEcCtD
Nepafenac—Hypertension—Prednisolone—rheumatoid arthritis	0.000218	0.00191	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—rheumatoid arthritis	0.000216	0.0051	CbGpPWpGaD
Nepafenac—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.000216	0.00189	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—rheumatoid arthritis	0.000213	0.00504	CbGpPWpGaD
Nepafenac—Hypertension—Hydrocortisone—rheumatoid arthritis	0.000212	0.00186	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—rheumatoid arthritis	0.00021	0.00496	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—SAA1—rheumatoid arthritis	0.000208	0.00492	CbGpPWpGaD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.000208	0.00182	CcSEcCtD
Nepafenac—PTGS2—S1P1 pathway—VEGFA—rheumatoid arthritis	0.000208	0.00491	CbGpPWpGaD
Nepafenac—Pruritus—Leflunomide—rheumatoid arthritis	0.000207	0.00182	CcSEcCtD
Nepafenac—PTGS2—C-MYB transcription factor network—GATA3—rheumatoid arthritis	0.000206	0.00485	CbGpPWpGaD
Nepafenac—Dizziness—Azathioprine—rheumatoid arthritis	0.000205	0.0018	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—COL2A1—rheumatoid arthritis	0.000203	0.00479	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—rheumatoid arthritis	0.000201	0.00474	CbGpPWpGaD
Nepafenac—Hypertension—Triamcinolone—rheumatoid arthritis	0.0002	0.00175	CcSEcCtD
Nepafenac—Hypertension—Methylprednisolone—rheumatoid arthritis	0.0002	0.00175	CcSEcCtD
Nepafenac—Vomiting—Azathioprine—rheumatoid arthritis	0.000197	0.00173	CcSEcCtD
Nepafenac—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000197	0.00173	CcSEcCtD
Nepafenac—Eye disorder—Prednisone—rheumatoid arthritis	0.000197	0.00172	CcSEcCtD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—rheumatoid arthritis	0.000196	0.00463	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—C5—rheumatoid arthritis	0.000196	0.00463	CbGpPWpGaD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.000195	0.00171	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000195	0.00171	CcSEcCtD
Nepafenac—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.000195	0.00171	CcSEcCtD
Nepafenac—PTGS2—C-MYB transcription factor network—CDK6—rheumatoid arthritis	0.000195	0.0046	CbGpPWpGaD
Nepafenac—Headache—Azathioprine—rheumatoid arthritis	0.000194	0.0017	CcSEcCtD
Nepafenac—Dizziness—Leflunomide—rheumatoid arthritis	0.000194	0.0017	CcSEcCtD
Nepafenac—Fenoprofen—PTGS2—rheumatoid arthritis	0.000193	0.0425	CrCbGaD
Nepafenac—Dry mouth—Triamcinolone—rheumatoid arthritis	0.000193	0.00169	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—rheumatoid arthritis	0.000192	0.00454	CbGpPWpGaD
Nepafenac—Angiopathy—Prednisone—rheumatoid arthritis	0.000191	0.00167	CcSEcCtD
Nepafenac—Immune system disorder—Prednisone—rheumatoid arthritis	0.00019	0.00167	CcSEcCtD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	0.000189	0.00447	CbGpPWpGaD
Nepafenac—Vomiting—Leflunomide—rheumatoid arthritis	0.000186	0.00163	CcSEcCtD
Nepafenac—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000185	0.00162	CcSEcCtD
Nepafenac—Nausea—Azathioprine—rheumatoid arthritis	0.000184	0.00161	CcSEcCtD
Nepafenac—Headache—Leflunomide—rheumatoid arthritis	0.000183	0.00161	CcSEcCtD
Nepafenac—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000183	0.00161	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—CAT—rheumatoid arthritis	0.000183	0.00432	CbGpPWpGaD
Nepafenac—Hypertension—Dexamethasone—rheumatoid arthritis	0.000182	0.00159	CcSEcCtD
Nepafenac—Hypertension—Betamethasone—rheumatoid arthritis	0.000182	0.00159	CcSEcCtD
Nepafenac—PTGS1—Overview of nanoparticle effects—IL6—rheumatoid arthritis	0.000181	0.00428	CbGpPWpGaD
Nepafenac—Mefenamic acid—PTGS2—rheumatoid arthritis	0.000179	0.0394	CrCbGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—TNF—rheumatoid arthritis	0.000178	0.00421	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—FCGR2A—rheumatoid arthritis	0.000176	0.00415	CbGpPWpGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—rheumatoid arthritis	0.000174	0.00412	CbGpPWpGaD
Nepafenac—Nausea—Leflunomide—rheumatoid arthritis	0.000174	0.00152	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—SOD2—rheumatoid arthritis	0.000174	0.0041	CbGpPWpGaD
Nepafenac—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000173	0.00152	CcSEcCtD
Nepafenac—Vision blurred—Prednisone—rheumatoid arthritis	0.000173	0.00151	CcSEcCtD
Nepafenac—Fenoprofen—ALB—rheumatoid arthritis	0.000172	0.0379	CrCbGaD
Nepafenac—PTGS2—Spinal Cord Injury—CXCL2—rheumatoid arthritis	0.000169	0.00398	CbGpPWpGaD
Nepafenac—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000168	0.00148	CcSEcCtD
Nepafenac—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000168	0.00148	CcSEcCtD
Nepafenac—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000166	0.00146	CcSEcCtD
Nepafenac—Eye disorder—Methotrexate—rheumatoid arthritis	0.000164	0.00144	CcSEcCtD
Nepafenac—Pruritus—Cyclosporine—rheumatoid arthritis	0.00016	0.0014	CcSEcCtD
Nepafenac—Angiopathy—Methotrexate—rheumatoid arthritis	0.000159	0.0014	CcSEcCtD
Nepafenac—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000159	0.00139	CcSEcCtD
Nepafenac—Hypertension—Prednisone—rheumatoid arthritis	0.000158	0.00139	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000155	0.00136	CcSEcCtD
Nepafenac—PTGS1—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	0.000153	0.00362	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—MTHFR—rheumatoid arthritis	0.000153	0.00361	CbGpPWpGaD
Nepafenac—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000151	0.00133	CcSEcCtD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	0.00015	0.00355	CbGpPWpGaD
Nepafenac—Dizziness—Cyclosporine—rheumatoid arthritis	0.000149	0.00131	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000148	0.0013	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000148	0.0013	CcSEcCtD
Nepafenac—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000148	0.0013	CcSEcCtD
Nepafenac—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000147	0.00128	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—CRP—rheumatoid arthritis	0.000145	0.00343	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CAT—rheumatoid arthritis	0.000145	0.00343	CbGpPWpGaD
Nepafenac—Skin disorder—Prednisone—rheumatoid arthritis	0.000145	0.00127	CcSEcCtD
Nepafenac—Oxcarbazepine—ALB—rheumatoid arthritis	0.000144	0.0318	CrCbGaD
Nepafenac—Vision blurred—Methotrexate—rheumatoid arthritis	0.000144	0.00126	CcSEcCtD
Nepafenac—PTGS2—Overview of nanoparticle effects—IL6—rheumatoid arthritis	0.000144	0.00339	CbGpPWpGaD
Nepafenac—Vomiting—Cyclosporine—rheumatoid arthritis	0.000144	0.00126	CcSEcCtD
Nepafenac—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000142	0.00125	CcSEcCtD
Nepafenac—Headache—Cyclosporine—rheumatoid arthritis	0.000142	0.00124	CcSEcCtD
Nepafenac—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000139	0.00122	CcSEcCtD
Nepafenac—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000139	0.00122	CcSEcCtD
Nepafenac—PTGS2—Selenium Micronutrient Network—SOD2—rheumatoid arthritis	0.000138	0.00325	CbGpPWpGaD
Nepafenac—Dizziness—Prednisolone—rheumatoid arthritis	0.000136	0.00119	CcSEcCtD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	0.000135	0.00318	CbGpPWpGaD
Nepafenac—Nausea—Cyclosporine—rheumatoid arthritis	0.000134	0.00118	CcSEcCtD
Nepafenac—Pruritus—Triamcinolone—rheumatoid arthritis	0.000134	0.00117	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—ICAM1—rheumatoid arthritis	0.000134	0.00316	CbGpPWpGaD
Nepafenac—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000133	0.00117	CcSEcCtD
Nepafenac—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000133	0.00116	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000129	0.00113	CcSEcCtD
Nepafenac—Headache—Prednisolone—rheumatoid arthritis	0.000129	0.00113	CcSEcCtD
Nepafenac—Diclofenac—PTGS2—rheumatoid arthritis	0.000129	0.0283	CrCbGaD
Nepafenac—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000128	0.00112	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—rheumatoid arthritis	0.000127	0.003	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CXCL10—rheumatoid arthritis	0.000127	0.00299	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	0.000126	0.00298	CbGpPWpGaD
Nepafenac—Headache—Hydrocortisone—rheumatoid arthritis	0.000126	0.0011	CcSEcCtD
Nepafenac—Dizziness—Triamcinolone—rheumatoid arthritis	0.000125	0.0011	CcSEcCtD
Nepafenac—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000125	0.00109	CcSEcCtD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—rheumatoid arthritis	0.000122	0.00289	CbGpPWpGaD
Nepafenac—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000122	0.00107	CcSEcCtD
Nepafenac—Nausea—Prednisolone—rheumatoid arthritis	0.000122	0.00107	CcSEcCtD
Nepafenac—Pruritus—Betamethasone—rheumatoid arthritis	0.000121	0.00106	CcSEcCtD
Nepafenac—Pruritus—Dexamethasone—rheumatoid arthritis	0.000121	0.00106	CcSEcCtD
Nepafenac—PTGS2—Selenium Micronutrient Network—MTHFR—rheumatoid arthritis	0.000121	0.00287	CbGpPWpGaD
Nepafenac—Skin disorder—Methotrexate—rheumatoid arthritis	0.000121	0.00106	CcSEcCtD
Nepafenac—Vomiting—Triamcinolone—rheumatoid arthritis	0.00012	0.00105	CcSEcCtD
Nepafenac—Vomiting—Methylprednisolone—rheumatoid arthritis	0.00012	0.00105	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—CCL2—rheumatoid arthritis	0.00012	0.00282	CbGpPWpGaD
Nepafenac—Nausea—Hydrocortisone—rheumatoid arthritis	0.000119	0.00105	CcSEcCtD
Nepafenac—Headache—Triamcinolone—rheumatoid arthritis	0.000118	0.00104	CcSEcCtD
Nepafenac—Headache—Methylprednisolone—rheumatoid arthritis	0.000118	0.00104	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—rheumatoid arthritis	0.000118	0.00279	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CRP—rheumatoid arthritis	0.000115	0.00273	CbGpPWpGaD
Nepafenac—Diclofenac—ALB—rheumatoid arthritis	0.000115	0.0252	CrCbGaD
Nepafenac—Ketoprofen—PTGS2—rheumatoid arthritis	0.000114	0.0251	CrCbGaD
Nepafenac—Dizziness—Dexamethasone—rheumatoid arthritis	0.000113	0.000995	CcSEcCtD
Nepafenac—Dizziness—Betamethasone—rheumatoid arthritis	0.000113	0.000995	CcSEcCtD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—rheumatoid arthritis	0.000113	0.00267	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—rheumatoid arthritis	0.000113	0.00266	CbGpPWpGaD
Nepafenac—Nausea—Triamcinolone—rheumatoid arthritis	0.000112	0.000985	CcSEcCtD
Nepafenac—Nausea—Methylprednisolone—rheumatoid arthritis	0.000112	0.000983	CcSEcCtD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	0.000112	0.00264	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	0.000112	0.00264	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—ALB—rheumatoid arthritis	0.000111	0.00263	CbGpPWpGaD
Nepafenac—Hypersensitivity—Prednisone—rheumatoid arthritis	0.00011	0.000965	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—IL1A—rheumatoid arthritis	0.000109	0.00258	CbGpPWpGaD
Nepafenac—Vomiting—Dexamethasone—rheumatoid arthritis	0.000109	0.000956	CcSEcCtD
Nepafenac—Vomiting—Betamethasone—rheumatoid arthritis	0.000109	0.000956	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000108	0.000945	CcSEcCtD
Nepafenac—Headache—Betamethasone—rheumatoid arthritis	0.000107	0.000942	CcSEcCtD
Nepafenac—Headache—Dexamethasone—rheumatoid arthritis	0.000107	0.000942	CcSEcCtD
Nepafenac—PTGS2—Selenium Micronutrient Network—ICAM1—rheumatoid arthritis	0.000106	0.00251	CbGpPWpGaD
Nepafenac—Pruritus—Prednisone—rheumatoid arthritis	0.000106	0.000927	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—IL4—rheumatoid arthritis	0.000106	0.00249	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	0.000104	0.00245	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—rheumatoid arthritis	0.000102	0.00242	CbGpPWpGaD
Nepafenac—Nausea—Betamethasone—rheumatoid arthritis	0.000102	0.000893	CcSEcCtD
Nepafenac—Nausea—Dexamethasone—rheumatoid arthritis	0.000102	0.000893	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—IFNG—rheumatoid arthritis	0.000102	0.0024	CbGpPWpGaD
Nepafenac—Ketoprofen—ALB—rheumatoid arthritis	0.000102	0.0224	CrCbGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	0.0001	0.00237	CbGpPWpGaD
Nepafenac—Dizziness—Prednisone—rheumatoid arthritis	9.88e-05	0.000866	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—PTGS2—rheumatoid arthritis	9.75e-05	0.0023	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—rheumatoid arthritis	9.64e-05	0.00228	CbGpPWpGaD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—rheumatoid arthritis	9.63e-05	0.00227	CbGpPWpGaD
Nepafenac—Vomiting—Prednisone—rheumatoid arthritis	9.5e-05	0.000833	CcSEcCtD
Nepafenac—PTGS2—Selenium Micronutrient Network—CCL2—rheumatoid arthritis	9.5e-05	0.00224	CbGpPWpGaD
Nepafenac—Headache—Prednisone—rheumatoid arthritis	9.36e-05	0.000821	CcSEcCtD
Nepafenac—Hypersensitivity—Methotrexate—rheumatoid arthritis	9.2e-05	0.000807	CcSEcCtD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	9.1e-05	0.00215	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL1B—rheumatoid arthritis	9.07e-05	0.00214	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—LEP—rheumatoid arthritis	8.94e-05	0.00211	CbGpPWpGaD
Nepafenac—Nausea—Prednisone—rheumatoid arthritis	8.88e-05	0.000778	CcSEcCtD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	8.87e-05	0.00209	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	8.87e-05	0.00209	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—ALB—rheumatoid arthritis	8.85e-05	0.00209	CbGpPWpGaD
Nepafenac—Pruritus—Methotrexate—rheumatoid arthritis	8.83e-05	0.000775	CcSEcCtD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—rheumatoid arthritis	8.78e-05	0.00207	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TLR4—rheumatoid arthritis	8.75e-05	0.00207	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	8.74e-05	0.00206	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—NFKB1—rheumatoid arthritis	8.46e-05	0.002	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—FADS2—rheumatoid arthritis	8.44e-05	0.00199	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—ICAM1—rheumatoid arthritis	8.39e-05	0.00198	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—NOS2—rheumatoid arthritis	8.33e-05	0.00197	CbGpPWpGaD
Nepafenac—Dizziness—Methotrexate—rheumatoid arthritis	8.26e-05	0.000724	CcSEcCtD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	8.24e-05	0.00195	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—rheumatoid arthritis	8.22e-05	0.00194	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—CD4—rheumatoid arthritis	8.09e-05	0.00191	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IFNG—rheumatoid arthritis	8.08e-05	0.00191	CbGpPWpGaD
Nepafenac—Vomiting—Methotrexate—rheumatoid arthritis	7.94e-05	0.000696	CcSEcCtD
Nepafenac—Headache—Methotrexate—rheumatoid arthritis	7.82e-05	0.000686	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—CCL2—rheumatoid arthritis	7.51e-05	0.00177	CbGpPWpGaD
Nepafenac—Nausea—Methotrexate—rheumatoid arthritis	7.42e-05	0.00065	CcSEcCtD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	7.23e-05	0.00171	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL1B—rheumatoid arthritis	7.2e-05	0.0017	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—POMC—rheumatoid arthritis	7.15e-05	0.00169	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	7.01e-05	0.00166	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	6.87e-05	0.00162	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—NFKB1—rheumatoid arthritis	6.72e-05	0.00159	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FADS2—rheumatoid arthritis	6.7e-05	0.00158	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	6.62e-05	0.00156	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—TNF—rheumatoid arthritis	6.58e-05	0.00155	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IFNG—rheumatoid arthritis	6.39e-05	0.00151	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CXCL8—rheumatoid arthritis	5.94e-05	0.0014	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SYVN1—rheumatoid arthritis	5.78e-05	0.00137	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL1B—rheumatoid arthritis	5.7e-05	0.00134	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL2—rheumatoid arthritis	5.67e-05	0.00134	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLD4—rheumatoid arthritis	5.63e-05	0.00133	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	5.57e-05	0.00131	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ACAN—rheumatoid arthritis	5.44e-05	0.00128	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MMP9—rheumatoid arthritis	5.37e-05	0.00127	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL6—rheumatoid arthritis	5.31e-05	0.00125	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—TNF—rheumatoid arthritis	5.23e-05	0.00123	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ACAN—rheumatoid arthritis	5.15e-05	0.00122	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC25A12—rheumatoid arthritis	5.11e-05	0.00121	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGES—rheumatoid arthritis	4.97e-05	0.00117	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GC—rheumatoid arthritis	4.97e-05	0.00117	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC25A12—rheumatoid arthritis	4.85e-05	0.00114	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLB1—rheumatoid arthritis	4.62e-05	0.00109	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLD4—rheumatoid arthritis	4.47e-05	0.00106	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TGFB1—rheumatoid arthritis	4.43e-05	0.00104	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PLB1—rheumatoid arthritis	4.38e-05	0.00103	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ACAN—rheumatoid arthritis	4.32e-05	0.00102	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL6—rheumatoid arthritis	4.22e-05	0.000996	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TNF—rheumatoid arthritis	4.13e-05	0.000976	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC25A12—rheumatoid arthritis	4.06e-05	0.000958	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MED1—rheumatoid arthritis	4.05e-05	0.000957	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RBPJ—rheumatoid arthritis	4.04e-05	0.000955	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GC—rheumatoid arthritis	3.95e-05	0.000932	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PTGES—rheumatoid arthritis	3.95e-05	0.000932	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—B3GNT2—rheumatoid arthritis	3.77e-05	0.00089	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ACP5—rheumatoid arthritis	3.77e-05	0.00089	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLB1—rheumatoid arthritis	3.67e-05	0.000866	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TP53—rheumatoid arthritis	3.64e-05	0.00086	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	3.61e-05	0.000853	CbGpPWpGaD
Nepafenac—PTGS2—Disease—B3GNT2—rheumatoid arthritis	3.57e-05	0.000843	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ACP5—rheumatoid arthritis	3.57e-05	0.000843	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	3.55e-05	0.000839	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—BGN—rheumatoid arthritis	3.39e-05	0.000801	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL6—rheumatoid arthritis	3.34e-05	0.000787	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	3.28e-05	0.000774	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MED1—rheumatoid arthritis	3.22e-05	0.00076	CbGpPWpGaD
Nepafenac—PTGS2—Disease—BGN—rheumatoid arthritis	3.22e-05	0.000759	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TLE3—rheumatoid arthritis	3.22e-05	0.000759	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALOX5—rheumatoid arthritis	3.12e-05	0.000737	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	3.01e-05	0.000711	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ACP5—rheumatoid arthritis	2.99e-05	0.000706	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—B3GNT2—rheumatoid arthritis	2.99e-05	0.000706	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC11A1—rheumatoid arthritis	2.94e-05	0.000693	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NFATC1—rheumatoid arthritis	2.91e-05	0.000688	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	2.81e-05	0.000664	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.75e-05	0.000648	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NCF2—rheumatoid arthritis	2.71e-05	0.000639	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—BGN—rheumatoid arthritis	2.69e-05	0.000636	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ENO1—rheumatoid arthritis	2.55e-05	0.000601	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.5e-05	0.000591	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SAA1—rheumatoid arthritis	2.49e-05	0.000588	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALOX5—rheumatoid arthritis	2.48e-05	0.000585	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	2.48e-05	0.000585	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NCF1—rheumatoid arthritis	2.44e-05	0.000576	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ENO1—rheumatoid arthritis	2.41e-05	0.00057	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CD28—rheumatoid arthritis	2.34e-05	0.000553	CbGpPWpGaD
Nepafenac—PTGS2—Disease—UBE2D1—rheumatoid arthritis	2.21e-05	0.000521	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.19e-05	0.000517	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.18e-05	0.000515	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ADRBK1—rheumatoid arthritis	2.14e-05	0.000505	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ENO1—rheumatoid arthritis	2.02e-05	0.000477	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.99e-05	0.000469	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PRKCQ—rheumatoid arthritis	1.98e-05	0.000466	CbGpPWpGaD
Nepafenac—PTGS2—Disease—STAT1—rheumatoid arthritis	1.94e-05	0.000458	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CAT—rheumatoid arthritis	1.83e-05	0.000433	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MTHFR—rheumatoid arthritis	1.53e-05	0.000361	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CCR5—rheumatoid arthritis	1.48e-05	0.00035	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CAT—rheumatoid arthritis	1.45e-05	0.000343	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MTHFR—rheumatoid arthritis	1.45e-05	0.000342	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HLA-A—rheumatoid arthritis	1.45e-05	0.000341	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6ST—rheumatoid arthritis	1.27e-05	0.000299	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS2—rheumatoid arthritis	1.26e-05	0.000297	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—POMC—rheumatoid arthritis	1.22e-05	0.000289	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CD80—rheumatoid arthritis	1.22e-05	0.000288	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MTHFR—rheumatoid arthritis	1.21e-05	0.000287	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6R—rheumatoid arthritis	1.13e-05	0.000267	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALB—rheumatoid arthritis	1.12e-05	0.000263	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NOS3—rheumatoid arthritis	1.07e-05	0.000252	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TYK2—rheumatoid arthritis	1.03e-05	0.000243	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS3—rheumatoid arthritis	1.01e-05	0.000239	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—rheumatoid arthritis	9.76e-06	0.00023	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—POMC—rheumatoid arthritis	9.71e-06	0.000229	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CD4—rheumatoid arthritis	9.32e-06	0.00022	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALB—rheumatoid arthritis	8.85e-06	0.000209	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NOS3—rheumatoid arthritis	8.47e-06	0.0002	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TGFB1—rheumatoid arthritis	6.69e-06	0.000158	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6—rheumatoid arthritis	5.04e-06	0.000119	CbGpPWpGaD
Nepafenac—PTGS2—skeletal joint—rheumatoid arthritis	4.44e-06	0.296	CbGeAlD
Nepafenac—PTGS2—synovial membrane of synovial joint—rheumatoid arthritis	3.37e-06	0.225	CbGeAlD
Nepafenac—PTGS2—cartilage tissue—rheumatoid arthritis	2.99e-06	0.199	CbGeAlD
Nepafenac—PTGS1—connective tissue—rheumatoid arthritis	7.77e-07	0.0518	CbGeAlD
Nepafenac—PTGS2—connective tissue—rheumatoid arthritis	7.43e-07	0.0495	CbGeAlD
Nepafenac—PTGS1—digestive system—rheumatoid arthritis	5.61e-07	0.0374	CbGeAlD
Nepafenac—PTGS2—lymphoid tissue—rheumatoid arthritis	5.43e-07	0.0362	CbGeAlD
Nepafenac—PTGS2—digestive system—rheumatoid arthritis	5.36e-07	0.0357	CbGeAlD
Nepafenac—PTGS1—tendon—rheumatoid arthritis	5.34e-07	0.0356	CbGeAlD
Nepafenac—PTGS2—tendon—rheumatoid arthritis	5.1e-07	0.034	CbGeAlD
